Skip to main content
. 2017 Sep 15;37(3):244–253. doi: 10.14366/usg.17041

Table 1.

Malignancy rate of each combined FNA/CNB result in nodules with a final diagnosis

Diagnostic result (category)a)
Final diagnosis (n=686)
Malignancy rate (%)
FNA CNB Benign (n=405) Malignancy (n=281)
Nondiagnostic Benign 67 0 0
Nondiagnostic AUS/FLUS 1 1 50
Nondiagnostic FN/SFN 1 0 0
Nondiagnostic Suspicion of malignancy 0 1 100
Nondiagnostic Malignant 0 5 100
Benign Nondiagnostic 5 0 0
Benign Benign 318 0 0
Benign AUS/FLUS 4 0 0
Benign FN/SFN 0 1 100
Benign Malignant 0 1 100
AUS/FLUS Benign 2 0 0
AUS/FLUS AUS/FLUS 3 4 57.1
AUS/FLUS FN/SFN 2 5 71.4
AUS/FLUS Suspicion of malignancy 0 7 100
AUS/FLUS Malignant 0 17 100
FN/SFN FN/SFN 2 1 33.3
Suspicion of malignancy Suspicion of malignancy 0 4 100
Suspicion of malignancy Malignant 0 59 100
Malignant Benign 0 1 100
Malignant AUS/FLUS 0 1 100
Malignant Suspicion of malignancy 0 4 100
Malignant Malignant 0 169 100

FNA, fine-needle aspiration; CNB, core needle biopsy; AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined significance; FN/SFN, follicular neoplasm/suspicious for a follicular neoplasm.

a)

Diagnoses according to the six categories of the Bethesda system.